Organon (OGN) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term.

Organon (NYSE:OGN) saw significant volatility last month with a 30% decline in its share price, coinciding with the company's announcement of decreased earnings and a reduction in its dividend ...

Organon (OGN) came out with quarterly earnings of $1.02 per share, beating the Zacks Consensus Estimate of $0.89 per share. This compares to earnings of $1.22 per share a year ago. These figures ...

The market expects Organon (OGN) to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended March 2025. This widely-known consensus outlook is ...

The latest price target for Organon (NYSE:OGN) was reported by Piper Sandler on May 15, 2025. The analyst firm set a price target for $18.00 expecting OGN to rise to within 12 months (a possible ...

One such company is Organon & Co (Symbol: OGN), which saw buying by Chief Human Resources Officer Aaron Falcione. Back on May 7, Falcione invested $48,235.00 into 5,500 shares of OGN, for a cost ...

Organon (NYSE:OGN) is set to report its first-quarter 2025 earnings on Thursday, May 1st, before the market opens. Analysts expect the pharmaceutical company to earn $0.89 (-27.0% year-over-year ...

JERSEY CITY, N.J. (AP) — JERSEY CITY, N.J. (AP) — Organon & Co. (OGN) on Thursday reported first-quarter net income of $87 million. The Jersey City, New Jersey-based company said it had net ...